Banwari Agarwal

Dr. Banwari Agarwal

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Journal of Hepatology
Verified
Journal Article
Closed access
RJRajiv Jalan
Rajiv Jalan
FSFaouzi Saliba
Faouzi Saliba
MPMarco Pavesi
Marco Pavesi
AAAlex Amoros
Alex Amoros
RMRichard Moreau
Richard Moreau
CCCANONIC study investigators of the EASL-CLIF Consortium
CANONIC study investigators of the EASL-CLIF Consortium

1 September 2018 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
CCCarolyn S Calfee
Carolyn S Calfee
KDKevin L Delucchi
Kevin L Delucchi
PSPratik Sinha
Pratik Sinha
MMMichael A Matthay
Michael A Matthay
JHJonathan Hackett
Jonathan Hackett
GSGareth Sellors
Gareth Sellors

1 February 2016 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
PDF file
MKMaria Kalafateli
Maria Kalafateli
KMKonstantinos Mantzoukis
Konstantinos Mantzoukis
YYYan Choi Yau
Yan Choi Yau
AMAli O. Mohammad
Ali O. Mohammad
SASimran Arora
Simran Arora
ETEmmanuel A. Tsochatzis
Emmanuel A. Tsochatzis
Background: Although malnutrition and sarcopenia are prevalent in cirrhosis, their impact on outcomes following liver transplantation is not well documented.Methods: The associations of nutritional status and sarcopenia with post‐transplant infections, requirement for mechanical ventilation, intensive care (ICU) and hospital stay, and 1 year mortality were assessed in 232 consecutive transplant recipients. Nutritional status and sarcopenia were assessed using the Royal Free Hospital‐Global Assessment (RFH‐GA) tool and the L3‐psoas muscle index (L3‐PMI) on CT, respectively.Results: A wide range of RFH‐SGA and L3‐PMI were observed within similar Model for End‐stage Liver Disease (MELD) sub‐categories. Malnutrition and sarcopenia were independent predictors of all outcomes. Post‐transplant infections were associated with MELD (OR = 1.055, 95%CI = 1.002–1.11) and severe malnutrition (OR = 6.55, 95%CI = 1.99–21.5); ventilation > 24 h with MELD (OR = 1.1, 95%CI = 1.036–1.168), severe malnutrition (OR = 8.5, 95%CI = 1.48–48.87) and suboptimal donor liver (OR = 2.326, 95%CI = 1.056–5.12); ICU stay > 5 days, with age (OR = 1.054, 95%CI = 1.004–1.106), MELD (OR = 1.137, 95%CI = 1.057–1.223) and severe malnutrition (OR = 7.46, 95%CI = 1.57–35.43); hospital stay > 20 days with male sex (OR = 2.107, 95%CI = 1.004–4.419) and L3‐PMI (OR = 0.996, 95%CI = 0.994–0.999); 1 year mortality with L3‐PMI (OR = 0.996, 95%CI = 0.992–0.999). Patients at the lowest L3‐PMI receiving suboptimal grafts had longer ICU/hospital stay and higher incidence of infections.Conclusions: Malnutrition and sarcopenia are associated with early post‐liver transplant morbidity/mortality. Allocation indices do not include nutritional status and may jeopardize outcomes in nutritionally compromised individuals.

1 October 2012 in Journal of Hepatology
Verified
Journal Article
Closed access
BABanwari Agarwal
Banwari Agarwal
GWGavin Wright
Gavin Wright
AGAlex Gatt
Alex Gatt
ARAnne Riddell
Anne Riddell
VVVishwaraj Vemala
Vishwaraj Vemala
ABAndrew Burroughs
Andrew Burroughs

1 June 2019 in The Lancet
Verified
Journal Article
Open access
CPCarol J Peden
Carol J Peden
TSTim Stephens
Tim Stephens
GMGraham Martin
Graham Martin
BKBrennan C Kahan
Brennan C Kahan
ATAnn Thomson
Ann Thomson
BHBeth Hale
Beth Hale
Emergency abdominal surgery is associated with poor patient outcomes. We studied the effectiveness of a national quality improvement (QI) programme to implement a care pathway to improve survival for these patients. We did a stepped-wedge cluster-randomised trial of patients aged 40 years or older undergoing emergency open major abdominal surgery. Eligible UK National Health Service (NHS) hospitals (those that had an emergency general surgical service, a substantial volume of emergency abdominal surgery cases, and contributed data to the National Emergency Laparotomy Audit) were organised into 15 geographical clusters and commenced the QI programme in a random order, based on a computer-generated random sequence, over an 85-week period with one geographical cluster commencing the intervention every 5 weeks from the second to the 16th time period. Patients were masked to the study group, but it was not possible to mask hospital staff or investigators. The primary outcome measure was mortality within 90 days of surgery. Analyses were done on an intention-to-treat basis. This study is registered with the ISRCTN registry, number ISRCTN80682973. Treatment took place between March 3, 2014, and Oct 19, 2015. 22 754 patients were assessed for elegibility. Of 15 873 eligible patients from 93 NHS hospitals, primary outcome data were analysed for 8482 patients in the usual care group and 7374 in the QI group. Eight patients in the usual care group and nine patients in the QI group were not included in the analysis because of missing primary outcome data. The primary outcome of 90-day mortality occurred in 1210 (16%) patients in the QI group compared with 1393 (16%) patients in the usual care group (HR 1·11, 0·96-1·28). No survival benefit was observed from this QI programme to implement a care pathway for patients undergoing emergency abdominal surgery. Future QI programmes should ensure that teams have both the time and resources needed to improve patient care. National Institute for Health Research Health Services and Delivery Research Programme.

10 October 2018 in Critical Care
Verified
Journal Article
Open access
PDF file
CECornelius Engelmann
Cornelius Engelmann
KTKaren Louise Thomsen
Karen Louise Thomsen
NZNekisa Zakeri
Nekisa Zakeri
MSMohammed Sheikh
Mohammed Sheikh
BABanwari Agarwal
Banwari Agarwal
RMRajeshwar P. Mookerjee
Rajeshwar P. Mookerjee
Acute-on-chronic liver failure (ACLF) is a severe complication of cirrhosis and is defined by organ failure and high rates of short-term mortality. Patients with ACLF are managed with multiorgan support in the intensive care unit (ICU). Currently, it is unclear when this supportive care becomes futile, particularly in patients who are not candidates for liver transplant. The aim of this study was to determine whether the currently available prognostic scores can identify patients with ACLF in whom prolonged ICU care is likely to be futile despite maximal treatment efforts. Data of 202 consecutive patients with ACLF admitted to the ICU at the Royal Free Hospital London between 2005 and 2012 were retrospectively analyzed. Prognostic scores for chronic liver diseases, such as Child-Pugh, Model for End-Stage Liver Disease (MELD), European Foundation for the study of chronic liver failure (CLIF-C) organ failure (OF), and CLIF-C ACLF, were calculated 48 hours after ICU admission and correlated with patient outcome after 28 days. The CLIF-C ACLF score, compared with all other scores, most accurately predicted 28-day mortality, with an area under the receiver operator characteristic of 0.8 (CLIF-C OF, 0.75; MELD, 0.68; Child-Pugh, 0.66). A CLIF-C ACLF score cutoff ≥ 70 identified patients with a 100% mortality within 28 days. These patients had elevated inflammatory parameters representing a systemic inflammatory response, most often renal failure, compared with patients below this cutoff. Patients with ACLF and high CLIF-C ACLF score (≥ 70) after 48 hours of intensive care may reach a threshold of futility for further ongoing intensive support. The best treatment options in this scenario remain to be determined but may include palliative care.